- Home
- DGX vs ZBH Comparison
DGX vs ZBH Comparison
Compare DGX & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- ZBH
- Stock Information
- Founded
- DGX 1967
- ZBH 1927
- Country
- DGX United States
- ZBH United States
- Employees
- DGX N/A
- ZBH N/A
- Industry
- DGX Medical Specialities
- ZBH Industrial Specialties
- Sector
- DGX Health Care
- ZBH Health Care
- Exchange
- DGX Nasdaq
- ZBH Nasdaq
- Market Cap
- DGX 20.5B
- ZBH 19.9B
- IPO Year
- DGX 1996
- ZBH N/A
- Fundamental
- Price
- DGX $192.77
- ZBH $96.48
- Analyst Decision
- DGX Buy
- ZBH Buy
- Analyst Count
- DGX 15
- ZBH 19
- Target Price
- DGX $194.07
- ZBH $108.56
- AVG Volume (30 Days)
- DGX 1.2M
- ZBH 2.5M
- Earning Date
- DGX 10-21-2025
- ZBH 11-05-2025
- Dividend Yield
- DGX 1.68%
- ZBH 1.03%
- EPS Growth
- DGX 14.49
- ZBH N/A
- EPS
- DGX 8.51
- ZBH 4.03
- Revenue
- DGX $10,850,000,000.00
- ZBH $8,010,900,000.00
- Revenue This Year
- DGX $12.37
- ZBH $8.20
- Revenue Next Year
- DGX $3.51
- ZBH $5.92
- P/E Ratio
- DGX $22.40
- ZBH $23.19
- Revenue Growth
- DGX 13.74
- ZBH 5.47
- 52 Week Low
- DGX $148.70
- ZBH $85.33
- 52 Week High
- DGX $197.55
- ZBH $114.44
- Technical
- Relative Strength Index (RSI)
- DGX 66.25
- ZBH 56.69
- Support Level
- DGX $184.18
- ZBH $88.49
- Resistance Level
- DGX $193.76
- ZBH $91.28
- Average True Range (ATR)
- DGX 4.26
- ZBH 2.22
- MACD
- DGX 1.01
- ZBH 0.74
- Stochastic Oscillator
- DGX 95.80
- ZBH 99.91
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.